ARCHIVES

FDA Simplifies Reporting Of Adverse Events

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

Duke wins Avon-NCI funding.

October 31, 2003

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994